The 4th Transatlantic Exchange in Oncology: Radiopharmaceutical Therapy Meets Oncology
With novel radiopharmaceutical therapies entering clinical trials and into clinical practice, the 2025 Transatlantic Exchange in Oncology will focus on bringing together key experts from Boston, USA and Paris, France to highlight the latest advances in the application of these targeted agents for oncology. The 1-day event will deliver a comprehensive overview of this highly competitive and dynamic area within the R&D landscape, enabling attendees to understand cutting-edge research as well as the challenges in bringing these therapies to routine clinical application.
Past scientific events
–
Opening and Welcome
Opening and Welcome
–
SESSION 1: Precision Oncology & Molecular Imaging: Early Detection and Characterization
SESSION 1: Precision Oncology & Molecular Imaging: Early Detection and Characterization
–
Keynote Address
Keynote Address
–
SESSION 2: How to Go From Non-Radiolabeled Target to a Radiolabeled Active Product
SESSION 2: How to Go From Non-Radiolabeled Target to a Radiolabeled Active Product
–
SESSION 3: Future Directions and Latest Clinical Applications
SESSION 3: Future Directions and Latest Clinical Applications
–
SESSION 4: Radioligand Therapies: Academia and Industry Perspectives
SESSION 4: Radioligand Therapies: Academia and Industry Perspectives
–
Closing Remarks
Closing Remarks